Operator
Greetings, and welcome to the Amphastar Prescribed drugs, Inc. Third Quarter Earnings Name. [Operator Instructions] Please be aware that sure statements made throughout this name relating to issues that aren’t historic details, together with, however not restricted to, administration’s outlook or predictions for the longer term intervals are forward-looking statements. These statements are primarily based solely on data that’s now out there to us. We encourage you to evaluate the session entitled Ahead-Trying Statements within the press launch issued right this moment and the presentation on the corporate’s web site.
Additionally, please discuss with our SEC filings, which will be discovered on our web site and the SEC’s web site for a dialogue of quite a few components that will influence our future efficiency. We will even focus on sure non-GAAP measures. Necessary data on our use of those measures and reconciliations to the U.S. GAAP could also be present in our earnings launch. Please be aware that this convention is being recorded.
Our audio system right this moment are Mr. Invoice Peters, CFO; Mr. Dan Dischner, Senior Vice President of Company Communications; and Mr. Tony Marrs, Govt Vice President of Regulatory Affairs and Medical Operations.
I’ll now flip the convention over to your host, Mr. Dan Dischner, Senior Vice President of Company Communications. Please go forward, sir.
